Enzyme's Movement May Be Key To New Cancer Drugs

A UA research team, including senior author Dr. Wolfgang Peti and Dr. Rebecca Page, both members of the BIO5 Institute, is the first group of scientists to figure out the full pathway for activating a protein kinase. "Kinases are one of the major cancer drug targets," said Dr. Peti. "If you know how a kinase works, you can definitely better design your drugs against it."